Aceto has entered into a ‘stalking-horse’ asset purchase agreement to offload its Rising Pharmaceuticals US generics business and its subsidiaries to Shore Suven Pharma for US$15 million, “plus the assumption of operating liabilities and customer obligations related to the acquired business on a cash-free and debt-free basis”.
Shore Suven Pharma is a joint venture between India’s Suven Life Sciences and Shore Pharma Investments, a firm founded by...





